Advertise here
Advertise here
Headlines

AI partners with liquid biopsy for ‘robust’ identification of women with ovarian cancer

Researchers presented results at the American Association for Cancer Research Annual Meeting showing that an artificial intelligence-driven algorithm using a liquid biopsy assay can differentiate women with ovarian cancer from healthy patients. The study found sensitivity rates ranging from 69% to 100% for different stages of ovarian cancer. The algorithm also had high specificity for detecting ovarian cancer and distinguishing between benign and malignant masses. While the study had limitations like a small sample size, researchers plan to validate their results in larger cohorts. The findings suggest a promising avenue for early detection and broad screening of ovarian cancer.

Source link

Advertise here
error: Content is protected !!